Men's Health News

RSS

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Sheffield Hallam University has joined the fight against one of the UK's biggest cancer killers by launching its first Massive Open Online Course (MOOC) in Enhancing Prostate Cancer Care.

9 Jul 2014

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study published this week in Nature Genetics.

8 Jul 2014

Study examines whether men who ride have higher risk of erectile dysfunction, infertility, prostate cancer

Cycling is a popular activity that offers clear health benefits, but there is an ongoing controversy about whether men who ride have a higher risk of urogenital disorders such as erectile dysfunction, infertility, or prostate cancer.

8 Jul 2014

Headbanging to Motörhead thought to have caused bleeding in the brain

A recent report in the Lancet describes the case of a man who developed bleeding in the brain after headbanging at a Motörhead concert.

4 Jul 2014

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.

3 Jul 2014

Study explores how surgical innovation can lead to adverse events for patients

Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.

3 Jul 2014

Testosterone therapy does not increase men's risk for heart attack, shows UTMB study

Testosterone prescriptions for older men in the United States have increased more than three-fold over the past decade. Recent studies linking testosterone use with increased risk of heart attack and stroke have caused widespread concern among patients and their families.

2 Jul 2014

Age of sperm donor does not affect outcome in terms of live birth

Despite emerging evidence of a decline in sperm quality with increasing age, an analysis of every first fertility treatment cycle performed in the UK using sperm donation shows that outcome in terms of live birth is not affected by the age of the sperm donor.

30 Jun 2014

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts.

28 Jun 2014

Men advised to take proactive approach to prevent hernia

As the preeminent hernia specialist in the Western United States, Dr. Shirin Towfigh has diagnosed and treated a number of patients through incisional hernia surgery and other cutting-edge techniques.

28 Jun 2014

Street football improves fitness, multiple health markers in homeless men

Research carried out by the Copenhagen Centre for Team Sport and Health in Denmark shows that street football (soccer) improves fitness and multiple health markers in homeless men.

26 Jun 2014

Patients receiving home oxygen therapy can lower risk of burns by shaving facial hair

Facial hair and home oxygen therapy can prove a dangerously combustible combination, a Mayo Clinic report published in the peer-reviewed medical journal Mayo Clinic Proceedings finds.

24 Jun 2014

Testosterone therapy may improve aerobic capacity in aging men

Testosterone replacement therapy may help older men who have limited mobility and low testosterone improve their aerobic capacity and lessen its decline with age, new research finds.

24 Jun 2014

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study.

23 Jun 2014

Low levels of testosterone decline physical function in elderly men

Elderly men with low levels of testosterone or other sex hormones have twice the likelihood of having declining physical function over two years' time compared with their peers who have the highest hormone levels, a new study from Australia finds.

23 Jun 2014

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Complementary medicines are generally being defined as medicines which are non-mainstream medicines and are mostly given together with conventional medicines.

23 Jun 2014

Bisexual men are vulnerable to STIs and other health problems

Bisexual men have many unmet public health needs, which leave them vulnerable to sexually transmitted infections (STIs) and other health problems. This new study from the Centers for Disease Control and Prevention (CDC) illuminates the behavioral, interpersonal, and social realities of men who have sex with men and women (MSMW), and it explores possible interventions to better serve their needs.

23 Jun 2014

Arthritis drug promotes hair growth in hairless man

A man with almost no hair on his body has grown a full head of it after a novel treatment by doctors at Yale University.

20 Jun 2014

Men with prostate cancer achieve stronger muscles and remain active through playing football

Men with prostate cancer aged 43‒74 achieve bigger and stronger muscles, improve functional capacity, gain positive social experiences and the desire to remain active through playing football for 12 weeks.

20 Jun 2014

Takeda decides to terminate development of orteronel for prostate cancer

Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).

19 Jun 2014

Men's Health News

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Study examines whether men who ride have higher risk of erectile dysfunction, infertility, prostate cancer

Headbanging to Motörhead thought to have caused bleeding in the brain

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

Study explores how surgical innovation can lead to adverse events for patients

Testosterone therapy does not increase men's risk for heart attack, shows UTMB study

Age of sperm donor does not affect outcome in terms of live birth

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

Men advised to take proactive approach to prevent hernia

Street football improves fitness, multiple health markers in homeless men

Patients receiving home oxygen therapy can lower risk of burns by shaving facial hair

Testosterone therapy may improve aerobic capacity in aging men

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Low levels of testosterone decline physical function in elderly men

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Bisexual men are vulnerable to STIs and other health problems

Arthritis drug promotes hair growth in hairless man

Men with prostate cancer achieve stronger muscles and remain active through playing football

Takeda decides to terminate development of orteronel for prostate cancer

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News